![[MePhe7]-Neurokinin B](https://file.medchemexpress.com/product_pic/hy-p3862.gif "Click to View [MePhe7]-Neurokinin B Product Detail")
Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
59 Results for "
NK3
" in MedChemExpress (MCE) Product Catalog:
Products (59)
59 Results for "NK3" in MCE Product Catalog:
6
6 Publications Verification
Target:
Forschungsgebiete:
SB-222200 is a potent, selective, orally active and blood-brain barrier (BBB) penetrant NK-3 receptor antagonist. SB-222200 is developed for central nervous system (CNS) disorders .
5
Target:
Forschungsgebiete:
Fezolinetant is an antagonist of the neurokinin 3 receptor (NK3R), used for the treatment of menopausal hot flushes.
3
3 Cited Publications
Art. -Nr.: HY-P0187
CAS. Nr.: 106128-89-6
Target:
Forschungsgebiete:
3
3 Cited Publications
Synonyms: MLE-4901; AZD2624; AZD4901
Target:
Forschungsgebiete:
Pavinetant (MLE-4901) is a neurokinin-3 receptor (NK3R) antagonist.
3
Target:
Forschungsgebiete:
Talnetant (SB 223412) is a selective, competitive, brain-permeable NK3 receptor antagonist with a Ki of 1.4 nM in hNK-3-CHO cells. Talnetant is 100-fold more selective for hNK-3 relative to the hNK-2 receptor and has no affinity for hNK-1. Talnetant can be used in schizophrenia-related studies [3].
1
1 Cited Publications
Target:
Forschungsgebiete:
L-732138 is a selective, potent and competitive neurokinin-1 (NK-1) receptor antagonist with an IC50 of 2.3 nM. L-732138 has 200-fold more potent in cloned human NK-1 receptors than cloned rat NK-1 receptors, and has > 1000-fold more potent than human NK-2 and NK-3 receptors. L-732138 can reduce hyperalgesia and has antitumor action .
1
1 Cited Publications
Synonyms: Pronetupitant chloride monohydrochloride
Target:
Forschungsgebiete:
Fosnetupitant chloride monohydrochloride (Pronetupitant chloride monohydrochloride) is an NK1 antagonist with pKi values of 9.5, 6.1 for human NK1 and NK3 receptor, respectively. Fosnetupitant chloride monohydrochloride is a methylene phosphate prodrug of Netupitant .
1
1 Cited Publications
Art. -Nr.: HY-18006
CAS. Nr.: 177707-12-9
Target:
Neurokinin Receptor Wnt Bcl-2 Family β-catenin Cyclin G-associated Kinase (GAK) VEGFR Caspase Cadherin Apoptosis
Forschungsgebiete:
Neurological Disease Metabolic Disease Inflammation/Immunology Cancer
NKP608 is a non-peptidic derivative of 4-aminopiperidine, a highly selective, orally active, neurokinin-1 (NK1) receptor antagonist with IC50 of 2.6 nM. NKP608 is active both in vitro and in vivo, showing extremely low affinity for NK2, NK3 receptors. NKP608 exerts its effects by blocking the NK₁ receptor, regulate cell proliferation and apoptosis, affect neurotransmitter functions and gastric mucosal repair mechanisms, and suppress the Wnt/β-catenin pathway in antitumor research. NKP608 is applicable to research related to various diseases, including cough, anxiety disorders, depression, gastric mucosal injury, and colorectal cancer [3] .
1
1 Cited Publications
Target:
Forschungsgebiete:
Synonyms: NT-814; BAY3427080
Target:
Forschungsgebiete:
Elinzanetant is an orally active and selective NK-1 and NK-3 receptor antagonist. Elinzanetant alleviates menopause-associated vasomotor symptoms, including hot flashes and night sweats. Elinzanetant reduces estradiol and progesterone levels. Elinzanetant can be used for the research of moderate to severe vasomotor and sleep disorders associated with menopause .
Art. -Nr.: HY-P0242
CAS. Nr.: 86933-75-7
Art. -Nr.: HY-P0242A
CAS. Nr.: 101536-55-4
Forschungsgebiete:
Cardiovascular Disease Inflammation/Immunology Endocrinology
Synonyms: SR142801
Target:
Forschungsgebiete:
Osanetant (SR142801) is a selective NK3 receptor antagonist. Osanetant produces anxiolytic- and antidepressant-like effects and is researched for schizophrenia .
Art. -Nr.: HY-P1192
CAS. Nr.: 133156-06-6
Target:
Forschungsgebiete:
Target:
Forschungsgebiete:
GR 159897 is a highly potent, selective, competitive, brain-penetrated non-peptide neurokinin 2 (NK2) receptor antagonist. GR 159897 has little or no affinity for NK1 and NK3 receptors. GR 159897 inhibits binding of [ 3H]GR100679 to human NK2 (hNK2)-CHO cells and rat colon membranes with pKis of 9.51 and 10, respectively. Antagonizes bronchoconstriction. Anxiolytic-like and anti-tumor effects .
Art. -Nr.: HY-117380
CAS. Nr.: 224961-34-6
Target:
Forschungsgebiete:
SB 235375 is a potent and selective antagonist of the human neurokinin-3 (hNK-3) receptor designed by optimizing the structure of 2-phenyl-4-quinolinecarboxylic acid amide. SB 235375 displays high affinity for the hNK-3 receptor, with significantly higher binding affinities than hNK-2 and hNK-1 receptors. In vitro studies demonstrated its ability to block NK-3 receptor-mediated contraction and calcium mobilization, while in vivo, SB 223412 demonstrated oral and intravenous activity against NK-3 receptor-driven responses in animal models .
Art. -Nr.: HY-P3862
CAS. Nr.: 110880-53-0
Target:
Forschungsgebiete:
Art. -Nr.: HY-P3854
CAS. Nr.: 141636-44-4
Target:
Forschungsgebiete:
Art. -Nr.: HY-P1277
CAS. Nr.: 141636-65-9
Target:
Forschungsgebiete:
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
